RIGEL PHARMACEUTICALS INC | Business Contracts

Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 2, 2022)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on May 3, 2022)

Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2022)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on March 1, 2022)

2022 Cash Incentive Plan (Filed With SEC on January 28, 2022)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on November 2, 2021)

Rigel Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan, as amended (Filed With SEC on August 3, 2021)

Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 3, 2021)

Non-employee Directors Compensation Policy (Filed With SEC on May 5, 2021)

2021 Cash Incentive Plan (Filed With SEC on February 3, 2021)

Offer Letter from Rigel Pharmaceuticals, Inc. to David Santos, dated July 13, 2020 (Filed With SEC on November 5, 2020)

Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 4, 2020)

Executive Severance Plan as amended (Filed With SEC on May 5, 2020)

Offer Letter from Rigel Pharmaceuticals, Inc. to Wolfgang Dummer, dated October 3, 2019 (Filed With SEC on February 27, 2020)

Description of Capital Stock (Filed With SEC on February 27, 2020)

2020 Cash Incentive Plan (Filed With SEC on November 22, 2019)

2018 Equity Incentive Plan, as amended (Filed With SEC on August 6, 2019)

Collaboration and License Agreements with Kissei Pharmaceutical Co., Ltd (Filed With SEC on February 28, 2019)

Supply Agreements with Kissei Pharmaceutical Co., Ltd (Filed With SEC on February 28, 2019)

2019 Cash Incentive Plan (Filed With SEC on February 1, 2019)

RIGEL PHARMACEUTICALS INC (27)